antihemophilic factor

(redirected from ReFacto)
Also found in: Thesaurus, Medical, Encyclopedia.

an·ti·he·mo·phil·ic factor

 (ăn′tē-hē′mə-fĭl′ĭk, ăn′tī-)
n. Abbr. AHF
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia Aantihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia A
clotting factor, coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
Sobi has extended the existing manufacturing agreement with Pfizer for the drug substance for ReFacto AF/XYNTHA.
M2 PHARMA-February 16, 2012-Sobi and Pfizer extend supply agreement for ReFacto AF/XYNTHA(C)2012 M2 COMMUNICATIONS
Last month, Sobi, which markets hemophilia A drug ReFacto AF in the Nordic region under a collaboration with Pfizer, unveiled a number of planned cost-saving measures, including 70 job cuts, mainly in preclinical research and manufacturing.